Wexford Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-23,176
| Closed | -$303K | – | 250 |
|
|
2025
Q1 | $303K | Buy |
23,176
+21,373
| +1,185% | +$3.09M | 0.08% | 161 |
|
|
2024
Q4 | $236K | Hold |
1,803
| – | – | 0.06% | 154 |
|
|
2024
Q3 | $281K | Sell |
1,803
-3,929
| -69% | -$634K | 0.07% | 132 |
|
|
2024
Q2 | $894K | Sell |
5,732
-32,163
| -85% | -$4.84M | 0.23% | 72 |
|
|
2024
Q1 | $5.13M | Sell |
37,895
-24,806
| -40% | -$3.28M | 1.05% | 28 |
|
|
2023
Q4 | $8.45M | Buy |
62,701
+18,304
| +41% | +$2.38M | 1.81% | 10 |
|
|
2023
Q3 | $6.01M | Buy |
44,397
+15,948
| +56% | +$2.18M | 1.37% | 20 |
|
|
2023
Q2 | $4.07M | Sell |
28,449
-10,058
| -26% | -$1.48M | 0.81% | 35 |
|
|
2023
Q1 | $5.35M | Buy |
38,507
+36,704
| +2,036% | +$4.94M | 1.11% | 23 |
|
|
2022
Q4 | $244K | Buy |
+1,803
| New | +$226K | 0.05% | 108 |
|
|
2022
Q3 | – | Sell |
-1,789
| Closed | -$236 | – | 141 |
|
|
2022
Q2 | $236 | Hold |
1,789
| – | – | 0.01% | 154 |
|
|
2022
Q1 | $237 | Buy |
1,789
+25
| +1% | +$3K | 0.01% | 136 |
|
|
2021
Q4 | $205 | Buy |
+1,764
| New | +$208K | 0.01% | 178 |
|
|
2021
Q2 | $210K | Buy |
+1,750
| New | +$192K | 0.03% | 155 |
|
|
2021
Q1 | – | Sell |
-68,000
| Closed | -$6.8M | – | 211 |
|
|
2020
Q4 | $6.8M | Buy |
68,000
+51,409
| +310% | +$5.45M | 1.06% | 21 |
|
|
2020
Q3 | $1.82M | Sell |
16,591
-22,575
| -58% | -$2.51M | 0.49% | 51 |
|
|
2020
Q2 | $4.14M | Buy |
+39,166
| New | +$4.04M | 1.05% | 31 |
|
|
2019
Q1 | – | Sell |
-98,787
| Closed | -$7.5M | – | 93 |
|
|
2018
Q4 | $7.5M | Buy |
+98,787
| New | +$7.71M | 0.64% | 25 |
|
|
2014
Q4 | – | Sell |
-80,739
| Closed | -$5.77M | – | 58 |
|
|
2014
Q3 | $5.77M | Buy |
+80,739
| New | +$5.91M | 0.53% | 30 |
|
Other funds holding AZN
